Sou Hu Cai Jing·2025-09-22 10:20Core Insights - The Medical Health R Index (480016) closed at 8194.9 points on September 22, with a slight increase of 0.05% and a trading volume of 32.204 billion yuan, indicating a turnover rate of 1.01% [1] Index Performance - Among the index constituents, 18 stocks rose while 32 stocks fell, with Ganli Pharmaceutical leading the gainers at a 3.76% increase, and Prologis Pharmaceutical leading the decliners with a 3.21% decrease [1] Top Constituents - The top ten constituents of the Medical Health R Index are as follows: - WuXi AppTec (sh603259) holds a weight of 13.58% and closed at 109.03 yuan, with a 0.26% increase [1] - Heng Rui Medicine (sh600276) has a weight of 10.87% and closed at 71.05 yuan, with a 2.01% increase [1] - Mindray Medical (sz300760) has a weight of 8.17% and closed at 237.15 yuan, with a 0.91% increase [1] - United Imaging Healthcare (sh688271) has a weight of 4.14% and closed at 145.93 yuan, with a 1.33% decrease [1] - Pianzai Shou (sh600436) has a weight of 3.91% and closed at 197.80 yuan, with a 0.72% decrease [1] - Aier Eye Hospital (sz300015) has a weight of 3.58% and closed at 12.37 yuan, with a 0.88% decrease [1] - Kelun Pharmaceutical (sz002422) has a weight of 2.59% and closed at 37.29 yuan, with a 2.39% increase [1] - Xinhecheng (sz002001) has a weight of 2.37% and closed at 23.73 yuan, with a 2.23% decrease [1] - Fosun Pharma (sh600196) has a weight of 2.26% and closed at 30.79 yuan, with a 0.45% decrease [1] - Tenzhuaosi (sz002252) has a weight of 2.07% and closed at 6.75 yuan, with a 0.30% decrease [1] Capital Flow - The Medical Health R Index constituents experienced a net outflow of 559 million yuan from institutional investors, while retail investors saw a net inflow of 583 million yuan [1] - Detailed capital flow for key stocks includes: - WuXi AppTec saw a net inflow of 27.8 million yuan from institutional investors [2] - Mindray Medical had a net inflow of 7.942 million yuan from institutional investors [2] - Heng Rui Medicine experienced a net outflow of 64.014 million yuan from institutional investors [2] - Ganli Pharmaceutical had a net inflow of 58.156 million yuan from institutional investors [2] - Kelun Pharmaceutical saw a net inflow of 42.940 million yuan from institutional investors [2]